Detroit BioPharma

Coming – New Date TBA

Rebuilding American Pharmaceutical Manufacturing

Date and Time

New Date TBA

–

Details will be provided upon RSVP approval

About this Event

The United States depends heavily on overseas manufacturers for many of the IV solutions and sterile injectables used every day in hospitals and healthcare systems. Recent shortages have exposed just how fragile these global supply chains have become, creating significant challenges for providers, patients, and government agencies alike.

Detroit BioPharma was created to help solve this problem.

The company plans to establish a next-generation pharmaceutical manufacturing campus in the city of Detroit. It is designed to expand domestic production of critical IV solutions and sterile injectables while strengthening America’s healthcare supply chain.

The company’s vision extends beyond a single manufacturing facility. Detroit BioPharma is developing what it believes will become the first site in a broader platform of advanced pharmaceutical manufacturing projects, combining modern automation, AI-enabled manufacturing, and Detroit’s deep industrial expertise to build resilient pharmaceutical production capacity in the United States.

During this executive briefing, attendees will learn:
  • Why shortages of IV solutions and sterile injectables have become a national healthcare challenge
  • The growing demand for domestic pharmaceutical manufacturing
  • The size and long-term outlook of the IV solutions and sterile injectable markets
  • Why Detroit has emerged as an ideal location for advanced pharmaceutical manufacturing
  • How Detroit BioPharma plans to leverage automation, advanced manufacturing, and strategic partnerships
  • The company’s development roadmap through facility completion

As healthcare systems, distributors, and government agencies increasingly prioritize reliable domestic manufacturing, Detroit BioPharma is positioning itself to address one of healthcare’s most important infrastructure challenges.

Join us to hear directly from the Stephen Shaya, MD, Chairman and Founder behind this ambitious initiative and learn how they plan to help strengthen America’s pharmaceutical manufacturing capabilities.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.